I didnt see any ONVO posts on this board, so any opinions welcome on todays NEWS
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo $ONVOhttps://t.co/qqgRlzGZXz